Management Team
Stephen R. Davis
Chief Executive Officer
Serge Stankovic, M.D., M.S.P.H.
President
Austin D. Kim
Executive Vice President,
General Counsel and Secretary
Brendan Teehan
Executive Vice President, Chief Operating Officer, Head of Commercial
Kathie M. Bishop, Ph.D.
Senior Vice President, Head of Rare Disease and External Innovation
Daryl DeKarske
Senior Vice President, Global Head of Regulatory Affairs and Head of Translational Sciences
Stephanie Fagan
Senior Vice President, Corporate Affairs and Chief Communications Officer
Julie Fisher
Senior Vice President, Marketing and Commercial Strategy
Bob Mischler
Senior Vice President, Strategy and Technology Operations
Mark Schneyer
Senior Vice President, Business Development, Chief Business Officer and Interim Chief Financial Officer
Ponni Subbiah, M.D., M.P.H.
Senior Vice President, Global Head of Medical Affairs and Chief Medical Officer
Mary Ellen Turner, M.D., M.P.H.
Senior Vice President, Pharmacovigilance and Corporate Safety Officer